These drugs in combination have synergistic action; for example the combination of an ACE inhibitor, beta-blocker and aldosterone receptor antagonist suppresses myocardial fibrosis in systolic heart failure.3 Therefore, combination therapy with drugs that block the SNS and RAAS systems may be the answer. The gene discussed is ACE; the disease is systolic heart failure.